# ACET (Adicet Bio, Inc.) - SEC EDGAR Financial Statements

> Adicet Bio, Inc. reported $128.9M in total assets and a net loss of $91.00M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ACET
- Markdown: https://convexityos.com/fundamentals/ACET.md
- SEC CIK: 0001720580
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:02 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001720580&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$95.55M | Operating profit |
| Net Income | FY 2025 | -$91.00M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$8.47 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$80.43M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $27.11M | Total debt: $12.10M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $99.13M | $99.32M | $106.0M | $71.25M | $48.94M | $34.33M | $23.69M | $14.72M | $16.84M |
| Total Operating Expenses | $122.1M | $127.6M | $152.0M | $97.54M | $71.16M | $57.09M | $32.38M | $23.14M | $18.88M |
| **Operating Income** | -$122.1M | -$127.6M | -$152.0M | -$72.55M | -$61.43M | -$39.19M | -$31.39M | -$14.96M | -$18.88M |
| **EBITDA** | -$115.7M | -$121.1M | -$145.9M | -$69.98M | -$59.90M | -$37.97M | -$30.15M | -$13.74M | -$18.88M |
| Interest Income | $5.78M | $10.71M | $9.98M | -- | -- | -- | -- | -- | -- |
| Interest Expense | $36K | $4.0K | $25K | $80K | $176K | $134K | -- | -- | -- |
| Income Before Tax | -$116.8M | -$117.1M | -$142.7M | -$69.79M | -$62.12M | -$39.49M | -$28.12M | -$9.89M | -$33.78M |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$125K | -$2.81M | $19K | -$589K | $0 |
| **Net Income** | -$116.8M | -$117.1M | -$142.7M | -$69.79M | -$62.00M | -$36.68M | -$28.14M | -$9.30M | -$33.78M |
| Basic EPS | -$16.95 | -$21.33 | -$52.96 | -$27.20 | -$32.00 | -$80.16 | -$210.40 | -$76.48 | -$1,077.76 |
| **Diluted EPS** | -$16.95 | -$21.33 | -$52.96 | -$27.20 | -$32.00 | -$80.16 | -$210.40 | -$76.48 | -$1,077.76 |
| Basic Shares Outstanding | 6.9M | 5.5M | 2.7M | 2.6M | 1.9M | 457.5K | 134.3K | 128.1K | 31.3K |
| Diluted Shares Outstanding | 6.9M | 5.5M | 2.7M | 2.6M | 1.9M | 457.5K | 133.7K | 121.7K | 31.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $15.63M | $18.45M | $17.49M | $25.04M | $22.85M | $28.42M | $22.81M | $23.27M |
| Total Operating Expenses | $19.80M | $22.30M | $21.57M | $31.89M | $27.95M | $32.39M | $29.89M | $30.74M |
| **Operating Income** | -$19.80M | -$22.30M | -$21.57M | -$31.89M | -$27.95M | -$32.39M | -$29.89M | -$30.74M |
| **EBITDA** | -$18.80M | -$21.10M | -$20.23M | -$30.41M | -$26.35M | -$30.79M | -$28.29M | -$29.12M |
| Interest Income | $972K | $1.17M | $1.34M | $1.52M | $1.17M | $1.40M | $1.68M | $2.07M |
| Interest Expense | $23K | $22K | $23K | $24K | $12K | $0 | $0 | $1.0K |
| Income Before Tax | -$18.88M | -$21.21M | -$20.24M | -$30.52M | -$26.86M | -$31.22M | -$28.21M | -$28.73M |
| Income Tax Expense | $1.0K | $143K | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$18.88M | -$21.36M | -$20.24M | -$30.52M | -$26.86M | -$31.22M | -$28.21M | -$28.73M |
| Basic EPS | -$1.76 | -$1.99 | -$1.88 | -- | -$4.72 | -$5.48 | -$4.96 | -- |
| **Diluted EPS** | -$1.76 | -$1.99 | -$1.88 | -- | -$4.72 | -$5.48 | -$4.96 | -- |
| Basic Shares Outstanding | 10.7M | 10.7M | 10.7M | -- | 5.7M | 5.7M | 5.7M | -- |
| Diluted Shares Outstanding | 10.7M | 10.7M | 10.7M | -- | 5.7M | 5.7M | 5.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $38.92M | $56.49M | $159.7M | $257.7M | $277.5M | $84.33M | $10.61M | $9.47M | $53.35M |
| Short-Term Investments | -- | -- | $0 | -- | $0 | $10.28M | $51.79M | -- | $0 |
| **Cash & Short-Term Investments** | $38.92M | $56.49M | $159.7M | $257.7M | $277.5M | $94.61M | $91.50M | $9.47M | $53.35M |
| Other Current Assets | $307K | $737K | $457K | $336K | $2.0K | $229K | $179K | $15K | $84K |
| **Total Current Assets** | $160.9M | $180.1M | $162.3M | $261.0M | $282.4M | $100.3M | $64.19M | $109.5M | $55.15M |
| Property, Plant & Equipment, Net | $16.53M | $22.52M | $26.78M | $28.71M | $14.64M | $2.79M | $2.12M | $321K | $39K |
| Goodwill | -- | -- | $0 | $19.46M | $19.46M | $20.09M | -- | -- | -- |
| Intangible Assets | -- | -- | -- | -- | $0 | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | $0 | $10.59M | -- | -- |
| Other Non-Current Assets | $76K | $428K | $822K | $1.21M | $1.89M | $1.84M | $410K | -- | -- |
| **Total Non-Current Assets** | $31.43M | $40.08M | $45.02M | $69.65M | $56.50M | $53.50M | $17.40M | $405K | $39K |
| **Total Assets** | $192.4M | $220.2M | $207.3M | $330.7M | $338.9M | $153.8M | $81.59M | $109.9M | $55.19M |
| Accounts Payable | $4.74M | $4.83M | $2.62M | $4.40M | $3.26M | $1.55M | $1.05M | $2.99M | $1.51M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $4.80M | $13.98M | $10.99M | -- | -- |
| **Total Current Liabilities** | $21.53M | $19.39M | $19.29M | $19.71M | $16.32M | $22.48M | $14.87M | $5.72M | $5.50M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $10.89M | -- | -- |
| Other Non-Current Liabilities | $62K | $116K | $130K | $114K | $115K | -- | $15K | $19K | -- |
| **Total Non-Current Liabilities** | $11.61M | $14.22M | $17.83M | $18.64M | $19.49M | $21.53M | $13.01M | $19K | $0 |
| **Total Liabilities** | $33.15M | $33.61M | $37.12M | $38.35M | $35.81M | $44.01M | $27.87M | $5.74M | $5.50M |
| **Total Debt (incl. Leases)** | $14.74M | $17.20M | $20.92M | $21.02M | $20.94M | $21.64M | -- | -- | -- |
| Common Stock | $10K | $5.0K | $4.0K | $4.0K | $4.0K | $2.0K | $4.0K | $3.0K | $1.0K |
| Retained Earnings | -$614.7M | -$497.9M | -$380.8M | -$238.1M | -$168.3M | -$106.3M | -$69.65M | -$71.39M | -$33.78M |
| Accumulated Other Comp. Income | $102K | $16K | $0 | $0 | $0 | $24K | $23K | -$41K | -- |
| **Total Stockholders' Equity** | $159.2M | $186.6M | $170.2M | $292.3M | $303.1M | $109.8M | -$60.37M | -$33.52M | -$26.95M |
| Total Equity | $159.2M | $186.6M | $170.2M | $292.3M | $303.1M | $109.8M | -$60.37M | -$33.52M | -$26.95M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $27.11M | $33.13M | $36.24M | $38.92M | $29.10M | $34.72M | $28.13M | $56.49M |
| **Cash & Short-Term Investments** | $27.11M | $33.13M | $36.24M | $38.92M | $29.10M | $34.72M | $28.13M | $56.49M |
| Other Current Assets | $490K | $441K | $348K | $307K | $619K | $690K | $478K | $737K |
| **Total Current Assets** | $103.4M | $120.8M | $140.1M | $160.9M | $106.5M | $127.7M | $153.6M | $180.1M |
| Property, Plant & Equipment, Net | $13.07M | $14.03M | $15.18M | $16.53M | $17.99M | $19.55M | $21.11M | $22.52M |
| Other Non-Current Assets | $80K | $80K | $78K | $76K | $110K | $225K | $314K | $428K |
| **Total Non-Current Assets** | $25.50M | $27.40M | $29.31M | $31.43M | $33.98M | $35.23M | $37.71M | $40.08M |
| **Total Assets** | $128.9M | $148.2M | $169.4M | $192.4M | $140.5M | $163.0M | $191.3M | $220.2M |
| Accounts Payable | $2.70M | $3.59M | $2.93M | $4.74M | $4.29M | $3.29M | $4.40M | $4.83M |
| **Total Current Liabilities** | $17.00M | $18.00M | $18.30M | $21.53M | $18.94M | $17.08M | $16.45M | $19.39M |
| Other Non-Current Liabilities | $0 | $0 | $0 | $62K | $125K | $116K | $116K | $116K |
| **Total Non-Current Liabilities** | $9.25M | $10.03M | $11.02M | $11.61M | $12.40M | $12.52M | $13.38M | $14.22M |
| **Total Liabilities** | $26.25M | $28.03M | $29.32M | $33.15M | $31.34M | $29.60M | $29.82M | $33.61M |
| **Total Debt (incl. Leases)** | $12.10M | $12.85M | $13.90M | $14.74M | $15.54M | $15.36M | $16.25M | $17.20M |
| Common Stock | $1.0K | $1.0K | $1.0K | $10K | $8.0K | $8.0K | $8.0K | $5.0K |
| Retained Earnings | -$675.2M | -$656.3M | -$634.9M | -$614.7M | -$584.2M | -$557.3M | -$526.1M | -$497.9M |
| Accumulated Other Comp. Income | -$175K | -$105K | -$37K | $102K | $56K | -$41K | -$9.0K | $16K |
| **Total Stockholders' Equity** | $102.7M | $120.1M | $140.1M | $159.2M | $109.1M | $133.4M | $161.4M | $186.6M |
| Total Equity | $102.7M | $120.1M | $140.1M | $159.2M | $109.1M | $133.4M | $161.4M | $186.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$116.8M | -$117.1M | -$142.7M | -$69.79M | -$62.00M | -$36.68M | -$28.14M | -$9.30M | -$33.78M |
| Depreciation & Amortization | $6.38M | $6.47M | $6.10M | $2.58M | $1.54M | $1.23M | $1.24M | $1.22M | $5.0K |
| Stock-Based Compensation | $14.27M | $22.23M | $20.26M | $17.13M | $12.51M | $5.26M | $1.18M | $2.48M | $470K |
| Change in Payables | $1.03M | $1.11M | -$1.68M | $1.71M | $1.14M | -$814K | $527K | -$282K | $1.39M |
| **Operating Cash Flow** | -$95.25M | -$92.38M | -$93.72M | -$44.77M | -$51.05M | -$41.55M | -$27.88M | -$18.18M | -$10.98M |
| Capital Expenditure | -$1.74M | -$1.12M | -$4.46M | -$16.78M | -$13.05M | -$990K | -$1.07M | -$876K | -$44K |
| **Free Cash Flow** | -$96.98M | -$93.50M | -$98.18M | -$61.55M | -$64.10M | -$42.54M | -$28.95M | -$19.06M | -$11.03M |
| Purchases of Investments | -- | -- | -- | -- | -- | -$5.70M | -$76.08M | -$15.18M | -- |
| **Investing Cash Flow** | $2.39M | -$119.2M | -$4.46M | -$16.78M | -$2.80M | $115.2M | -$47.93M | -$16.06M | -$44K |
| Common Stock Issued | $0 | $19.27M | $0 | $43.36M | $238.1M | -- | -- | -- | -- |
| **Financing Cash Flow** | $75.25M | $111.3M | $236K | $41.51M | $242.7M | $303K | $76.94M | $11.05M | $64.38M |
| **Net Change in Cash** | -$17.61M | -$100.3M | -$97.94M | -$20.04M | $188.8M | $73.97M | $1.13M | -$23.19M | $53.35M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18.88M | -$21.36M | -$20.24M | -$30.52M | -$26.86M | -$31.22M | -$28.21M | -$28.73M |
| Depreciation & Amortization | $1.00M | $1.20M | $1.34M | $1.47M | $1.60M | $1.60M | $1.60M | $1.62M |
| Stock-Based Compensation | $1.50M | $1.40M | $1.30M | $5.65M | $2.50M | $2.90M | $3.18M | $3.77M |
| Change in Payables | -$892K | $664K | -$1.80M | $307K | $1.21M | -$1.12M | $629K | $1.15M |
| **Operating Cash Flow** | -$17.92M | -$19.82M | -$21.49M | -$20.91M | -$22.31M | -$26.63M | -$25.40M | -$24.10M |
| Capital Expenditure | -$56K | -$202K | -$37K | $10K | -$209K | -$47K | -$1.49M | -$176K |
| **Free Cash Flow** | -$17.98M | -$20.02M | -$21.53M | -$20.90M | -$22.52M | -$26.68M | -$26.89M | -$24.28M |
| **Investing Cash Flow** | $11.60M | $16.65M | $18.88M | -$44.53M | $16.84M | $32.95M | -$2.86M | -$22.12M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $1.0K | $58K | -$65K | $75.23M | -$150K | $267K | -$104K | $137K |
| **Net Change in Cash** | -$6.32M | -$3.11M | -$2.68M | $9.79M | -$5.62M | $6.59M | -$28.36M | -$46.08M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -73.4% | -62.8% | -83.8% | -23.9% | -20.5% | -33.4% | -- | -- | -- |
| Return on Assets (ROA) | -60.7% | -53.2% | -68.8% | -21.1% | -18.3% | -23.8% | -34.5% | -8.5% | -61.2% |
| Current Ratio | 7.47x | 9.29x | 8.41x | 13.25x | 17.31x | 4.46x | 4.32x | 19.16x | 10.02x |
| Quick Ratio | 1.81x | 2.91x | 8.28x | 13.07x | 17.01x | 4.21x | 6.16x | 1.66x | 9.70x |
| Debt to Equity | 0.09x | 0.09x | 0.12x | 0.07x | 0.07x | 0.20x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -88.6% | -82.4% | -77.7% | -73.4% | -105.4% | -89.0% | -72.7% | -62.8% |
| Return on Assets (ROA) | -70.6% | -66.8% | -64.3% | -60.7% | -81.9% | -72.8% | -61.3% | -53.2% |
| Current Ratio | 6.09x | 6.71x | 7.65x | 7.47x | 5.62x | 7.48x | 9.34x | 9.29x |
| Quick Ratio | 1.60x | 1.84x | 1.98x | 1.81x | 1.54x | 2.03x | 1.71x | 2.91x |
| Debt to Equity | 0.12x | 0.11x | 0.10x | 0.09x | 0.14x | 0.12x | 0.10x | 0.09x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
